A case study in unethical transgressive bioethics: "Letter of Concern from Bioethicists" about the prenatal administration of dexamethasone

American Journal of Bioethics

Volumn 10, Issue 9, 2010, Pages 35-45

  McCullough, Laurence B ^a   Chervenak, Frank A ^b   Brent, Robert L ^c   Hippen, Benjamin ^d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d Nephrology Associates   (United States)

Author keywords

Bioethics; Fetal treatment; Human subjects research; Methodological integrity; Off label use of medications; Public advocacy; Transgressive bioethics

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; STEROID 21 MONOOXYGENASE;

ARTICLE; CLINICAL TRIAL; CONGENITAL ADRENAL HYPERPLASIA; CONGENITAL MALFORMATION; DRUG ADMINISTRATION; ENZYMOLOGY; ETHICIST; ETHICS; FEMALE; FEMALE GENITAL SYSTEM; FETUS DISEASE; FOOD AND DRUG ADMINISTRATION; GONADAL DISEASE; HERMAPHRODITISM; HUMAN; HUMAN EXPERIMENT; INFORMED CONSENT; MALE; METABOLISM; OFF LABEL DRUG USE; PATIENT REFERRAL; PLASTIC SURGERY; PREGNANCY; PRENATAL DIAGNOSIS; PROFESSIONAL STANDARD; STANDARD; UNITED STATES; WRITING; ADRENAL HYPERPLASIA, CONGENITAL; CLINICAL TRIAL (TOPIC); COMPLICATION; DISORDERS OF SEX DEVELOPMENT; FETAL DISEASES; STANDARDS; VIRILISM;

ADRENAL HYPERPLASIA, CONGENITAL; CLINICAL TRIALS AS TOPIC; CORRESPONDENCE AS TOPIC; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; ETHICISTS; ETHICS COMMITTEES, RESEARCH; FEMALE; FETAL DISEASES; GENITALIA, FEMALE; GLUCOCORTICOIDS; HERMAPHRODITISM; HUMANS; INFORMED CONSENT; MALE; OFF-LABEL USE; PREGNANCY; PRENATAL DIAGNOSIS; RECONSTRUCTIVE SURGICAL PROCEDURES; REFERRAL AND CONSULTATION; STEROID 21-HYDROXYLASE; THERAPEUTIC HUMAN EXPERIMENTATION; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VIRILISM; DISORDERS OF SEX DEVELOPMENT;

EID: 77956408319     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265161.2010.499745     Document Type: Article

References (32)

1. CARES Foundation. 2009. Cares Foundation history. Available at: http://www.caresfoundation.org/productcart/pc/historycares.html (accessed April 22, 2010).
2. Cognitive functions in children with CAH treated prenatally with dexamethasone. 2009. Growth, Genetics & Hormones 25(1). Available at: http://www.gghjournal.com/volume23/2/ab18.cfm (accessed April 22, 2010).
3. De Crecchio, L. 1865. Sopra un caso di apparenze virili in una donna. Morgagni 7: 154-188.
4. De Grazia, D., and T. L. Beauchamp. 2001. Philosophy. In Methods in medical ethics, ed. J. Sugarman and D.P. Sulmasy, 31-46.Washington, DC: Georgetown University Press.
5. Diamond, D. A., J. Ecker, I. Holm, S. Kornetsky, C. Mitchell, and N. Spack. 2010 Not fetal cosmetology. The Hastings Center Bioethics Forum, March 8. Available at: http://www.thehastingscenter.org/Bioethicsforum/Post.aspx?id=4528&bl ogid=140 (accessed April 22, 2010).
6. Dresser, R., and J. Freder. 2009. Off-label prescribing: A call for tightened professional and government oversight. Journal of Law, Medicine and Ethics 37(3): 476-486.
7. fetaldex.org. 2010a. Letter of concern of bioethicists. Available at:http://fetaldex.org/letterbioethics.html (accessed April 22, 2010).
8. fetaldex.org. 2010b. Welcome to fetaldex.org. Available at:http://www.fetaldex.org/home.html (accessed April 22, 2010).
9. Forest, M. G., H. Bétuel, and M. David. 1987. Traitement antenatal de l'hyperplase congenital des surrénales par deficit en 21-hydroxylase: Etude multicentrique. Annales Endocrinologiques 48(6):31-34.
10. French, N. P., R. Hagan, S. F. Evans, A. Mullan, and J. P. Newnham. 2004. Repeated antenatal corticosteroids: Effects of cerebral palsy and childhood behavior. American Journal of Obstetrics and Gynecology 190(3): 588-595.
11. Grunberger,W., and E. Boschitsch. 1981. Report of 22 cases of congenital adrenal genital syndrome (AGS) observed in the reproductive age group. Gebutshschilfe Frauenheilkunde 41(11): 787-790 [in German].
12. Hirvikoski, T., A. Nordenström, T. Lindholm, F. Lindblad, E. M. Ritzén,A.Wedell, and S. Lajic. 2007. Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone. Journal of Clinical Endocrinology and Metabolism 92(2): 542-548.
13. Hirvikoski, T., A. Nordenström, T. Lindholm, F. Lindblad, E. M. Ritzén, and S. Lajic. 2008. Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: Does dexamethasone cause behavioural problems? European Journal of Endocrinology 159: 309-316.
14. Joint LWPES/ESPE CAH Working Group. 2002. Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Journal of Clinical Endocrinology & Metabolism 87(9): 4048-4053.
15. Jonsen, A. R. 1998. The birth of bioethics. New York: Oxford University Press.
16. Karaviti, L. P., A. B. Mercado, M. B. Mercado, P. W Speiser, M. Buegeleisen, C. Crawford, L. Antonion, P. C. White, and M. I. New. 1992. Prenatal diagnosis/treatment in families at risk for infants with steroid 21-hydroxylase deficiency (congenital adrenal hyperplasia). Journal of Steroid Biochemistry and Molecular Biology 41(3-8): 445-451.
17. Krakow, D. 2008. Medical and surgical complications of pregnancy. In Danforth's obstetrics and gynecology, 9th ed., ed. R. S. Gibbs, B. Y. Karlan, A. F. Haney, and I. E. Nygaard, chap. 17 (not paginated). Philadelphia: Lippincott Williams & Wilkins. Electronic book. Available at: http://ovidsp.tx.ovid.com.ezproxyhost.library.tmc.edu/sp-2.3.1/ovidweb.c gi?QS2=434f4e1a73d37e8c8b72a1e2ee153b38efd0e739b339295af5018b2c628fa0def 5c8062b6fde957df7302f2c517463f44515e61dd4ef574a54267a75b096c729e62e665b6 211119b48ae0fbdd1773b3e3385443ad36425f85a46982ccc28756b7fcda6f24c680983d afd6e94c6dd2247812f06fc13c6ee6503f2589ddf1e0b999f648425d16cdf1d7358be9f7 eb6e68b65d22b3addb6fcac2615808d33d557dd9bc264a93a78e983528b8fe6eef27250c f6fd3e56001c800212dd759da5d5e41b1d224958aeceb22126bc3bb8007368e29c8e7383 3df255d8b58ae8e65cd4c6ef77c9fbdaf2207661b24d782ff9f8063592eb280799b2233c 8bd5e022e4f42a629ea3421681ffdb7 (accessed April 22, 2010).
18. Lajic S., S. Nordenström, E.M. Ritzén, and A.Wedell. 2004. Prenatal treatment of congenital adrenal hyperplasia. European Journal of Endocrinology 151(suppl.3): U63-U69.
19. Lewis, E. N., M. R. Griffin, P. G. Szilagyi, Y. Zhu, K. M. Edwards, and K. A. Poehling. 2007. Childhood influenza: Number needed to vaccinate to prevent 1 hospitalization or outpatient visit. Pediatrics 120(3): 467-472.
20. Lindemann, H., E. K. Feder, and A. Dreger. 2010a. Fetal cosmetology. In The Hastings Center Bioethics Forum, February 8 (not paginated). Available at: http://www.thehastingscenter.org/Bioethicsforum/Post.aspx?id=4470&bl ogid=140 (accessed April 22, 2010).
21. Lindemann, H., E. K. Feder, and A. Dreger. 2010b. Prenatal dex: Update and omnibus reply. In The Hastings Center Bioethics Forum, March 18 (not paginated). Available at: http://www.thehastingscenter.org/Bioethicsforum/Post.aspx?id=4569&bl ogid=140 (accessed April 22, 2010).
22. Meyer-Bahlberg, H. F., C. Dolezai, S. W. Baker, A. D. Carlson, J. S. Obeid, and M. I. New. 2004. Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone. Journal of Clinical Endocrinology and Metabolism 89(2): 610-614.
23. Miller,W. L. 1999. Dexamethasone treatment of congenital adrenal hyperplasia in utero: An experimental therapy of unproven safety. Journal of Urology 162(2): 537-540.
24. National Institutes of Health Consensus Development Panel. 2001. Antenatal corticosteroids revisited: repeat courses-National Institutes of Health Consensus Development Conference Statement, August 17-18, 2000. Obstetrics and Gynecology 98(1): 144-150).
25. New, M. I. 1990. Prenatal diagnosis and treatment of adrenogenital syndrome (steroid 21-hydroxylase deficiency). Developmental Pharmacology and Therapeutics 15(3-4): 200-210.
26. New, M. I., A. Carlson, J. Obeid, I. Marshall, M. S. Cabrere, A. Goseco, K. Lin-Su, A. S. Putnam, J. Q. Wei, and R. C. Wilson. 2001. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. Journal of Clinical Endocrinology and Metabolism 86(12): 5651-5657.
27. Pernick, M. S. 2009. Bioethics and history. In The Cambridge world history of medical ethics, ed. R. B. Baker and L. B. McCullough, 16-20. New York: Cambridge University Press.
28. Sandberg, D. W. 2009. Editors comments. Growth, Genetics & Hormones 25(1). Available at: http://www.gghjournal.com/volume23/2/ab18.cfm (accessed April 22, 2010).
29. Speiser, P. W., and W. L. Miller. 2008. Prenatal treatment of classic CAHwith dexamethasone: Pro vs. con. EndocrineNews April: 15-18.
30. Sulmasy, D. P., and J. Sugarman. 2001. Themanymethods of medical ethics (or thirteen ways of looking at a blackbird). In Methods in medical ethics, ed. J. Sugarman and D. P. Sulmasy, 3-18.Washington, DC: Georgetown University Press.
31. Trautman, P. D., H. F. LMeyer-Bahlberg, J. Postelnek, and M. I.New. 1995. Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study. Psychoneuroendocrinology 20(4): 439-449.
32. Uno, H., S. Eisele, A. Sakai, et al. 1994. Neurotoxicity of glucocorticoids in the primate brain. Hormones and Behavior 28: 336-348.